Print

Samaritan Pharmaceuticals, Inc. (SPHC) Acquires Commercialization Rights to Market and Distribute Abiogen Pharma's Cancer Drug Abioklad in Greece, Cyprus and Turkey  
3/19/2008 10:29:47 AM

LAS VEGAS, March 19, 2008 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals, Inc. (OTCBB:SPHC) (http://www.samaritanpharma.com), a biopharmaceutical company committed to commercializing new innovative therapeutic drugs, has acquired the rights from Abiogen Pharma of Italy to distribute and sell the specialty pharmaceutical, Abioklad (Disodium Clodronate), in Greece, Cyprus, and Turkey.
//-->